FIG4 Gene CMT4J NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The FIG4 Gene CMT4J NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for neurological conditions. This advanced genetic analysis specifically targets mutations in the FIG4 gene, which plays a critical role in maintaining proper nerve function and cellular processes. Charcot-Marie-Tooth disease type 4J (CMT4J) is a rare autosomal recessive form of peripheral neuropathy that can significantly impact quality of life. Early and accurate diagnosis through this specialized test enables healthcare providers to implement targeted interventions and management strategies.
What Does the Test Measure?
This sophisticated genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the entire FIG4 gene for pathogenic variants. The test specifically detects:
- Point mutations, insertions, and deletions in the FIG4 gene
- Autosomal recessive inheritance patterns associated with CMT4J
- Specific genetic markers linked to progressive peripheral neuropathy
- Variants affecting phosphoinositide phosphatase function
Who Should Consider This Test?
This genetic test is recommended for individuals presenting with specific clinical symptoms or family history patterns:
- Patients experiencing progressive muscle weakness in hands and feet
- Individuals with sensory loss or numbness in extremities
- Those with foot deformities or gait abnormalities
- Patients with reduced or absent deep tendon reflexes
- Individuals with a family history of peripheral neuropathy
- Children showing delayed motor development milestones
- Patients with unexplained muscle atrophy
Clinical Benefits of Genetic Testing
Undergoing the FIG4 Gene CMT4J NGS Genetic DNA Test provides numerous advantages for patients and healthcare providers:
- Accurate Diagnosis: Provides definitive identification of CMT4J, eliminating diagnostic uncertainty
- Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
- Family Planning: Offers crucial information for genetic counseling and reproductive decisions
- Proactive Management: Facilitates early intervention and symptom management strategies
- Research Contribution: Contributes to ongoing neurological research and treatment development
Understanding Your Test Results
Our comprehensive genetic report provides clear, actionable information:
- Positive Result: Indicates the presence of pathogenic FIG4 gene mutations associated with CMT4J
- Negative Result: Suggests no detectable mutations in the analyzed regions of the FIG4 gene
- Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications
- Carrier Status: Determines if an individual carries one copy of a mutated gene
All results are accompanied by detailed interpretation and recommendations from our certified genetic counselors.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about neurological symptoms affect your quality of life. The FIG4 Gene CMT4J NGS Genetic DNA Test provides the clarity needed to make informed healthcare decisions. Our team of genetic specialists and neurologists are committed to supporting you throughout the testing process and beyond.
Ready to schedule your test? Call us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and receiving personalized care.
